Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03029390Phase 4Unknown
Phase 4, randomised, double-blind trial (2 arms), sponsored by Universidad de Guadalajara. Primary endpoints: Fasting glucose levels at 14 weeks, Postprandial glucose levels at 14 weeks and 4 more. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03029390.